Al Ali H, Rodrigo G, Lambert D
PLoS One. 2025; 20(1):e0313119.
PMID: 39820183
PMC: 11737703.
DOI: 10.1371/journal.pone.0313119.
Chen X, Yin L, Jia W, Wang N, Xu C, Hou B
Front Endocrinol (Lausanne). 2019; 10:453.
PMID: 31379736
PMC: 6660256.
DOI: 10.3389/fendo.2019.00453.
Oral E, Halici Z, Cinar I, Ozcan E, Kutlu Z
Clin Psychopharmacol Neurosci. 2019; 17(2):211-221.
PMID: 30905121
PMC: 6478082.
DOI: 10.9758/cpn.2019.17.2.211.
Cadirci E, Ugan R, Dincer B, Gundogdu B, Cinar I, Akpinar E
Naunyn Schmiedebergs Arch Pharmacol. 2018; 392(2):135-145.
PMID: 30353214
DOI: 10.1007/s00210-018-1571-8.
Wang Y, Tian W, Xiu C, Yan M, Wang S, Mei Y
Clin Rheumatol. 2018; 38(1):29-35.
PMID: 29362961
DOI: 10.1007/s10067-018-3978-5.
The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features.
Castel H, Desrues L, Joubert J, Tonon M, Prezeau L, Chabbert M
Front Endocrinol (Lausanne). 2017; 8:76.
PMID: 28487672
PMC: 5403833.
DOI: 10.3389/fendo.2017.00076.
Plasma urotensin-2 level and Thr21Met but not Ser89Asn polymorphisms of the urotensin-2 gene are associated with migraines.
Geyik S, Ergun S, Kuzudisli S, Sensoy F, Temiz E, Altunisik E
J Headache Pain. 2016; 17:36.
PMID: 27090416
PMC: 4835397.
DOI: 10.1186/s10194-016-0623-z.
Urotensin-II-Mediated Reactive Oxygen Species Generation via NADPH Oxidase Pathway Contributes to Hepatic Oval Cell Proliferation.
Yu X, Wang P, Shi Z, Dong K, Feng P, Wang H
PLoS One. 2015; 10(12):e0144433.
PMID: 26658815
PMC: 4676694.
DOI: 10.1371/journal.pone.0144433.
Up-regulation of urotensin II and its receptor contributes to human hepatocellular carcinoma growth via activation of the PKC, ERK1/2, and p38 MAPK signaling pathways.
Yu X, Wang P, Shi Z, Dong K, Feng P, Wang H
Molecules. 2014; 19(12):20768-79.
PMID: 25514221
PMC: 6271171.
DOI: 10.3390/molecules191220768.
Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes.
Watson A, Olukman M, Koulis C, Tu Y, Samijono D, Yuen D
Diabetologia. 2013; 56(5):1155-65.
PMID: 23344731
DOI: 10.1007/s00125-013-2837-9.
Urotensin-II: More Than a Mediator for Kidney.
Balat A, Buyukcelik M
Int J Nephrol. 2012; 2012:249790.
PMID: 23094156
PMC: 3474241.
DOI: 10.1155/2012/249790.
Effect of the urotensin-II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with Type 2 diabetes mellitus.
Sidharta P, Rave K, Heinemann L, Chiossi E, Krahenbuhl S, Dingemanse J
Br J Clin Pharmacol. 2009; 68(4):502-10.
PMID: 19843053
PMC: 2780275.
DOI: 10.1111/j.1365-2125.2009.03480.x.
Desensitisation of native and recombinant human urotensin-II receptors.
Batuwangala M, Calo G, Guerrini R, Ng L, McDonald J, Lambert D
Naunyn Schmiedebergs Arch Pharmacol. 2009; 380(5):451-7.
PMID: 19680632
DOI: 10.1007/s00210-009-0441-9.
Role of urotensin II and its receptor in health and disease.
McDonald J, Batuwangala M, Lambert D
J Anesth. 2007; 21(3):378-89.
PMID: 17680191
DOI: 10.1007/s00540-007-0524-z.
Form-deprivation myopia in chick induces limited changes in retinal gene expression.
McGlinn A, Baldwin D, Tobias J, Budak M, Khurana T, Stone R
Invest Ophthalmol Vis Sci. 2007; 48(8):3430-6.
PMID: 17652709
PMC: 1983368.
DOI: 10.1167/iovs.06-1538.
Does cigarette smoking increase plasma urotensin II concentrations?.
Gold S, Thompson J, Williams J, Helm E, Sadler J, Song W
Eur J Clin Pharmacol. 2007; 63(3):253-7.
PMID: 17252242
DOI: 10.1007/s00228-006-0252-6.
Photolabelling the urotensin II receptor reveals distinct agonist- and partial-agonist-binding sites.
Holleran B, Beaulieu M, Proulx C, Lavigne P, Escher E, Leduc R
Biochem J. 2006; 402(1):51-61.
PMID: 17064254
PMC: 1783990.
DOI: 10.1042/BJ20060943.